Skip to main content
SpringerLink
Log in

The Patient with an LVAD Presenting for Non-cardiac Surgery: Perioperative Considerations

  • Cardiovascular Anesthesia (A Mahajan, Section Editor)
  • Published:
Current Anesthesiology Reports Aims and scope Submit manuscript

Abstract

Heart failure refractory to medical therapy may be treated by heart transplantation. Given that the need for organs outpaces supply, ventricular assist devices (VADs) were developed to support hemodynamics in the patient with end-stage heart failure. Initially approved only in those patients awaiting transplantation, VADs are now implanted for long-term therapy in patients ineligible for transplantation. Many of these patients may subsequently present for non-cardiac surgery, possibly in a non-transplant center. General anesthesiologists may therefore be expected to care for these patients, especially in an emergency. This review presents an overview of current VADs as well as their unique preoperative and intraoperative anesthetic considerations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Roger VL. Epidemiology of heart failure. Circ Res. 2013;113:646–59.

    Article  CAS  Google Scholar 

  2. Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6:606–19.

    Article  CAS  Google Scholar 

  3. Khush KK, Zaroff JG, Nguyen J, et al. Longer waiting time increases mortality in heart transplantation: an instrumental variable analysis. J Heart Lung Transplant. 2015;34(4):S71.

    Article  Google Scholar 

  4. Hunt SA, Frazier OH. Mechanical circulatory support and cardiac transplantation. Circulation. 1998;97:2079–90.

    Article  CAS  Google Scholar 

  5. Berger RL, Merin G, Carr J, et al. Successful use of a left ventricular assist device in cardiogenic shock from massive postoperative myocardial infarction. J Thorac Cardiovasc Surg. 1979;78(4):626–32.

    Article  CAS  Google Scholar 

  6. Rose EA, Gellins AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435–43.

    Article  CAS  Google Scholar 

  7. • Kirklin JK, Naftel DC, Pagani FD, et al. Sixth INTERMACS annual report: a 10,000-patient database. J Heart Lung Transplant. 2014;33:555–64. This report includes data from over 10,000 patients with VADs, including their demographics and adverse events.

  8. Peterzen B, Granfeldt H, Lonn U, et al. Management of patients with end-stage heart disease treated with an implantable left ventricular assist device in a nontransplanting center. J Cardiothorac Vasc Anesth. 2000;14:438–43.

    Article  CAS  Google Scholar 

  9. Stone ME, Soong W, Krol M, et al. The anesthetic considerations in patients with ventricular assist devices presenting for noncardiac surgery: a review of eight cases. Anesth Analg. 2002;95:42–9.

    Article  Google Scholar 

  10. Thoratec Ventricular Assist Device (VAD) system: instructions for use. http://www.thoratec.com/_assets/download-tracker/VAD-IFU-15003M-ENGLISH.pdf. Accessed 7 Jul 2015.

  11. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51.

    Article  CAS  Google Scholar 

  12. 2nd Generation Centrimag System Operating Manual: For use with Centrimag and PediMag Blood Pumping Systems. http://www.thoratec.com/_assets/download-tracker/centrimag/PL-0047%20Rev%2006%20Thor_US%20Operating%20Manual%20-%202nd%20Gen%20CentriMag%20System.pdf. Accessed 7 Jul 2015.

  13. Bhama JK, Kormos RL, Toyoda Y, et al. Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. J Heart Lung Transplant. 2009;28:971–6.

    Article  Google Scholar 

  14. John R, Liao K, Lietz K, et al. Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg. 2007;134(2):351–8.

    Article  Google Scholar 

  15. De Robertis F, Rogers P, Amrani M, et al. Bridge to decision using the Levitronix CentriMag Short-term ventricular assist device. J Heart Lung Transplant. 2008;27:474–8.

    Article  Google Scholar 

  16. Thoratec Corporation Heartmate II® Left Ventricular Assist System: instructions for use. http://www.thoratec.com/_assets/download-tracker/HMII/106020/106020_G_HM2_EN_IFU_NA.pdf. Accessed 7 Jul 2015.

  17. Jarvik 2000: How it works. http://www.jarvikheart.com/basic.asp?id=21. Accessed 9 Jul 2015.

  18. Jarvik R. Evaluation of the Jarvik 2000 left ventricular assist system with post-auricular connector: destination therapy study. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US); 2000-[cited 2015 Jul 9]. https://clinicaltrials.gov/ct2/show/NCT01627821?term=jarvik&rank=2. NLM Identifier: NCT01627821.

  19. HeartWare Ventricular Assist System: Instructions for use. http://www.heartware.com/sites/default/files/uploads/docs/ifu00001.20_us_pma_ifu_060614.pdf. Accessed 12 Jul 2015.

  20. Slaughter MS, Pagani FD, McGee EC, et al. HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. J Heart Lung Transplant. 2013;32(7):675–83.

    Article  Google Scholar 

  21. Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trail to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52(19):1584–8.

    Article  Google Scholar 

  22. Burkhoff D, Cohen H, Brunckhorst C, et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152:469.e-1–8.

    Article  Google Scholar 

  23. •• Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29:S1–39. This review gives a detailed presentation of the outpatient management of a patient with a VAD, including outlines for treatment of device problems.

  24. Stehlik J, Nelson DM, Kfoury AG, et al. Outcome of noncardiac surgery in patients with ventricular assist devices. Am J Cardiol. 2009;103:709–12.

    Article  Google Scholar 

  25. Brown JB, Hallinan WM, Massey HT, et al. Does the need for noncardiac surgery during ventricular assist device therapy impact clinical outcome? Surgery. 2009;146:627–34.

    Article  Google Scholar 

  26. John R, Kamdar F, Eckman P, et al. Lessons learned from experience with over 100 consecutive Heartmate II left ventricular assist devices. Ann Thorac Surg. 2011;92(5):1593–600.

    Article  Google Scholar 

  27. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the Post-REMATCH era. Circulation. 2007;116:497–505.

    Article  Google Scholar 

  28. Hannan MM, Husain S, Mattner F, et al. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant. 2011;30(4):375–84.

    Article  Google Scholar 

  29. Gordon RJ, Weinberg AD, Pagani FD. Prospective, multicenter study of ventricular assist device infections. Circulation. 2013;127:691–702.

    Article  Google Scholar 

  30. Nishimura RA, Carabello BA, Faxon DP, et al. ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis. Circulation. 2008;118:887–96.

    Article  Google Scholar 

  31. Amir O, Bracey AW, Smart FW, et al. A successful anticoagulation protocol for the first Heartmate® II implantation in the United States. Tex Heart Inst J. 2005;32(3):399–401.

    PubMed  PubMed Central  Google Scholar 

  32. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–96.

    Article  CAS  Google Scholar 

  33. Boyle AJ, Russell SD, Teuteberg JJ, et al. Low thromboembolism and pump thrombosis with the Heartmate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant. 2009;28:881–7.

    Article  Google Scholar 

  34. • Barbara DW, Wetzel DR, Pulido JN, et al. The perioperative management of patients with left ventricular assist devices undergoing noncardiac surgery. Mayo Clin Proc. 2013;88(7):674–82. This retrospective study of 33 LVAD patients undergoing noncardiac surgery at a single medical center details anticoagulation strategies and postoperative complications.

  35. • Morgan JA, Paone G, Nemeh HW, et al. Non-cardiac surgery in patients on long-term left ventricular assist device support. J Heart Lung Transplant. 2012;31:757–63. This retrospective study examines 20 patients undergoing 25 noncardiac procedures, with data on types of surgical cases and complications.

  36. Geisen U, Heilmann C, Beyersdorf F, et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg. 2008;33:679–84.

    Article  Google Scholar 

  37. Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med. 2003;349:343–9.

    Article  Google Scholar 

  38. Demirozu ZT, Radovancevic R, Hochman LF, et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2011;30(8):849–53.

    PubMed  Google Scholar 

  39. Murkin JM, Arango M. Near-infrared spectroscopy as an index of brain and tissue oxygenation. Br J Anaesth. 2009;103(S1):i3–13.

    Article  Google Scholar 

  40. • Nelson EW, Heinke T, Finley A, et al. Management of LVAD patients for noncardiac surgery: a single-institution study. J Cardiothorac Vasc Anesth. 2015;29(4):898–900. This retrospective review examined 35 patients undergoing noncardiac surgery at a single medical center. Anesthetic management, including use of arterial cannulation for blood pressure monitoring, was detailed.

  41. •• Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary. J Am Coll Cardiol. 2014;64(22):2373–405. These updated guidelines include important information on the perioperative assessment and management of patients presenting for noncardiac surgery.

  42. Koh DB, Gowardman JR, Rickard CM, et al. Prospective study of peripheral arterial catheter infection and comparison with concurrently sited central venous catheters. Crit Care Med. 2008;36:397–402.

    Article  Google Scholar 

  43. Thunberg CA, Gaitan BD, Arabia FA, et al. Ventricular assist devices today and tomorrow. J Cardiothorac Vasc Anesth. 2010;24(4):656–80.

    Article  Google Scholar 

  44. Horlocker TT, Wedel DJ, Rowlingson JC, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (third edition). Reg Anesth Pain Med. 2010;35:64–101.

    Article  CAS  Google Scholar 

  45. • Sheu R, Joshi B, High K, et al. Perioperative management of patients with left ventricular assist devices undergoing noncardiac procedures: a survey of current practices. J Cardiothorac Vasc Anesth. 2015;29(1):17–26. This is a recent survey study of current anesthetic management practices for LVAD patients undergoing noncardiac procedures.

  46. Buxton AE, Fisher JD, Josephson KL, et al. Prevention of sudden death with coronary artery disease: the multicenter unsustained tachycardia trial (MUSTT). Prog Cardiovasc Dis. 1993;36(3):215–26.

    Article  CAS  Google Scholar 

  47. Busch MC, Haap M, Kristen A, et al. Asymptomatic sustained ventricular fibrillation in a patient with left ventricular assist device. Ann Emerg Med. 2011;57:25–8.

    Article  Google Scholar 

  48. Patel P, Williams JG, Brice JH. Sustained ventricular fibrillation in an alert patient: preserved hemodynamics with a left ventricular assist device. Prehosp Emerg Care. 2011;15:533–6.

    Article  Google Scholar 

  49. Sims DB, Rosner G, Uriel N, et al. Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device. Pacing Clin Electrophysiol. 2011;35:e144. doi:https://doi.org/10.1111/j.1540-8159.2011.03159.x.

    Article  Google Scholar 

  50. Bedi M, Kormos R, Winowich S, et al. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol. 2007;99:1151–3.

    Article  Google Scholar 

  51. Ochiai Y, McCarthy PM, Smedira NG, et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation. 2002;106:I-198–202.

    Google Scholar 

  52. Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the Heartmate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139:1316–24.

    Article  Google Scholar 

  53. Santamore WP, Gray LA. Left ventricular contributions to right ventricular systolic function during LVAD support. Ann Thorac Surg. 1996;61:350–6.

    Article  CAS  Google Scholar 

  54. •• Hahn RT, Abraham T, Adams MS, et al. Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr. 2013;26:921–64. These are recently updated guidelines for performing a transesophageal echocardiographic examination, with detailed explanations of how to acquire the views as well as several graphics and videos.

Download references

Author information

Authors and Affiliations

  1. UCLA Department of Anesthesiology and Perioperative Medicine, David Geffen School of Medicine, Box 957403, RRMC 3325, Los Angeles, CA, 90095-7403, USA

    Emily Methangkool & Kimberly Howard-Quijano

Authors
  1. Emily Methangkool
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kimberly Howard-Quijano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emily Methangkool.

Additional information

This article is part of the Topical Collection on Cardiovascular Anesthesia.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Methangkool, E., Howard-Quijano, K. The Patient with an LVAD Presenting for Non-cardiac Surgery: Perioperative Considerations. Curr Anesthesiol Rep 5, 438–444 (2015). https://doi.org/10.1007/s40140-015-0135-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40140-015-0135-4

Keywords

Search

Navigation